TrialThe breast journal2018

Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.

Eunpi Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.